Nothing Special   »   [go: up one dir, main page]

HUP0401953A2 - Biotinszármazékok - Google Patents

Biotinszármazékok

Info

Publication number
HUP0401953A2
HUP0401953A2 HU0401953A HUP0401953A HUP0401953A2 HU P0401953 A2 HUP0401953 A2 HU P0401953A2 HU 0401953 A HU0401953 A HU 0401953A HU P0401953 A HUP0401953 A HU P0401953A HU P0401953 A2 HUP0401953 A2 HU P0401953A2
Authority
HU
Hungary
Prior art keywords
biotin derivatives
body fluids
mammalian body
extracorporeal
extracorporeal device
Prior art date
Application number
HU0401953A
Other languages
English (en)
Inventor
Bengt Sandberg
Scott Wilbur
Rune Nilsson
Original Assignee
Department Of Radiation Oncology, University Of Washington
Mitra Medical Technology Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Department Of Radiation Oncology, University Of Washington, Mitra Medical Technology Ab filed Critical Department Of Radiation Oncology, University Of Washington
Publication of HUP0401953A2 publication Critical patent/HUP0401953A2/hu
Publication of HUP0401953A3 publication Critical patent/HUP0401953A3/hu

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin, biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A találmány tárgya eljárás extrakorporális eszköz kondicionálására;valamint eljárás toxikus anyag emlős testfolyadékokból történőextrakorporális eltávolítására, emlősökben előforduló állapot vagybetegség diagnózisával vagy kezelésével összefüggésben, melyeljárásokban a reagensek alkalmasak toxikus anyag eltávolítására emlőstestfolyadékokból; és extrakorporális eszköz, mely a reagensttartalmazza. Ó
HU0401953A 2000-06-16 2001-06-18 Biotin derivatives HUP0401953A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (2)

Publication Number Publication Date
HUP0401953A2 true HUP0401953A2 (hu) 2004-12-28
HUP0401953A3 HUP0401953A3 (en) 2005-06-28

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401953A HUP0401953A3 (en) 2000-06-16 2001-06-18 Biotin derivatives

Country Status (14)

Country Link
EP (1) EP1289563B1 (hu)
JP (1) JP2004503299A (hu)
CN (1) CN1457260A (hu)
AT (1) ATE469661T1 (hu)
AU (2) AU7476101A (hu)
BR (1) BR0111726A (hu)
CA (1) CA2412495C (hu)
DE (1) DE60142286D1 (hu)
HU (1) HUP0401953A3 (hu)
IL (1) IL153449A0 (hu)
MX (1) MXPA02012438A (hu)
NO (1) NO20025931L (hu)
PL (1) PL359328A1 (hu)
WO (1) WO2001095857A2 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1813614T3 (pl) * 2006-01-25 2012-03-30 Sanofi Sa Środki cytotoksyczne zawierające nowe pochodne tomaymycyny
AU2008322998B2 (en) * 2007-11-12 2013-10-03 Chreto Aps Dual affinity polypeptides for purification
KR20140037105A (ko) * 2011-05-27 2014-03-26 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
DK2714684T3 (en) 2011-05-27 2018-11-26 Ambrx Inc COMPOSITIONS CONTAINING, PROCEDURE INVOLVING, AND APPLICATIONS OF NON-NATURAL AMINO ACID-BONDED DOLASTATIN DERIVATIVES
US11286285B2 (en) 2014-02-18 2022-03-29 Savid Therapeutics Inc. Modified biotin, streptavidin mutant, and usage of them
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
KR102413013B1 (ko) * 2016-12-27 2022-06-23 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
WO2018122205A2 (en) 2016-12-27 2018-07-05 F. Hoffmann-La Roche Ag Novel biotin-specific monoclonal antibody and use thereof
WO2018151301A1 (ja) * 2017-02-17 2018-08-23 三井化学株式会社 抗体医薬の開発に資する創薬標的タンパク質の同定方法及び標的タンパク質に対する抗体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
CA2412495C (en) 2011-02-01
MXPA02012438A (es) 2004-09-06
ATE469661T1 (de) 2010-06-15
CA2412495A1 (en) 2001-12-20
IL153449A0 (en) 2003-07-06
JP2004503299A (ja) 2004-02-05
BR0111726A (pt) 2003-05-27
DE60142286D1 (de) 2010-07-15
NO20025931D0 (no) 2002-12-11
AU2001274761B2 (en) 2005-06-16
WO2001095857A2 (en) 2001-12-20
EP1289563A2 (en) 2003-03-12
AU7476101A (en) 2001-12-24
WO2001095857A3 (en) 2002-03-28
EP1289563B1 (en) 2010-06-02
HUP0401953A3 (en) 2005-06-28
NO20025931L (no) 2003-02-14
PL359328A1 (en) 2004-08-23
CN1457260A (zh) 2003-11-19

Similar Documents

Publication Publication Date Title
WO2006128192A3 (en) Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
ATE438853T1 (de) Diagnostische testvorrichtung
ATE336942T1 (de) Vorrichtung zur entnahme biologischer flüssigkeiten und analytenmessung
EE200300005A (et) Meetod konformse haiguse diagnoosimiseks või tuvastamiseks, selleks vajalik katsemenetlus, reaktiivikomplekt ning seade
WO2003069332A3 (en) Detection and/or monitoring of synuclein-related diseases
EP2305809A3 (en) Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
WO2002018652A3 (en) Method for detection of htr and htert telomerase-associated rna in plasma or serum
WO2004069174A3 (en) Monitoring and treatment of amyotrophic lateral sclerosis
BR9814386B1 (pt) aparelhos e métodos para determinar a concentração de um componente medicamente significante de um fluido biológico.
WO2002084266A3 (en) Biological measurement system
MX340547B (es) Equipos de prueba de diagnostico.
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
EP1480251A3 (en) System of analyzing complex mixtures of biological and other fluids to identify biological state information
HUP0401953A2 (hu) Biotinszármazékok
GB2441944A (en) Fieldbus system with shared redundancy system
WO2005080985A3 (en) Methods and compositions for detecting and treating autoimmune diseases
SE0002287D0 (sv) Biotinderivat
AU2001263943A1 (en) Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient
WO2003048734A3 (en) Detection of matrix metalloproteinase rna in plasma and serum
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
WO2002053016A3 (en) Compounds and methods for the diagnosis and treatment of babesia infection
SE9403953D0 (sv) Sequence-based diagnosis
ATE432770T1 (de) Verfahren und vorrichtung zur isolierung und/oder bestimmung eines analyten
WO2004113926A3 (en) Diagnosis of pre-eclampsia
SE0102896D0 (sv) System and method for blood analysis

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees